Pulmonx Historical Income Statement
| LUNG Stock | USD 6.79 0.37 5.76% |
Historical analysis of Pulmonx Corp income statement accounts such as Gross Profit of 53.3 M can show how well Pulmonx Corp performed in making a profits. Evaluating Pulmonx Corp income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Pulmonx Corp's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Pulmonx Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pulmonx Corp is a good buy for the upcoming year.
Pulmonx |
About Pulmonx Income Statement Analysis
Pulmonx Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Pulmonx Corp shareholders. The income statement also shows Pulmonx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Pulmonx Corp Income Statement Chart
Add Fundamental
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Pulmonx Corp. It is also known as Pulmonx Corp overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Pulmonx Corp's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Pulmonx Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.At this time, Pulmonx Corp's Total Revenue is most likely to increase significantly in the upcoming years. The Pulmonx Corp's current Gross Profit is estimated to increase to about 53.3 M, while Net Loss is forecasted to increase to (58.2 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 3.2M | 4.0M | 1.9M | 1.8M | Interest Income | 400K | 1.5M | 4.8M | 5.0M |
Pulmonx Corp income statement Correlations
Click cells to compare fundamentals
Pulmonx Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pulmonx Corp income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 2.3M | 3.2M | 829K | 1.1M | 3.2M | 3.4M | |
| Selling General Administrative | 34.2M | 44.6M | 64.8M | 77.0M | 89.8M | 94.3M | |
| Total Revenue | 32.6M | 32.7M | 48.4M | 53.7M | 68.7M | 72.1M | |
| Gross Profit | 22.4M | 21.2M | 35.6M | 39.9M | 50.8M | 53.3M | |
| Operating Income | (17.8M) | (32.3M) | (47.3M) | (58.6M) | (61.9M) | (58.8M) | |
| Net Income From Continuing Ops | (20.7M) | (32.2M) | (48.7M) | (58.9M) | (61.2M) | (58.2M) | |
| Ebit | (17.8M) | (28.8M) | (49.8M) | (60.0M) | (57.0M) | (54.2M) | |
| Research Development | 6.0M | 7.5M | 13.1M | 15.4M | 18.1M | 19.0M | |
| Cost Of Revenue | 10.2M | 11.5M | 12.8M | 13.8M | 17.9M | 18.8M | |
| Total Operating Expenses | 40.3M | 53.5M | 82.9M | 98.5M | 112.7M | 118.3M | |
| Income Before Tax | (20.3M) | (32.0M) | (48.3M) | (58.6M) | (60.3M) | (57.3M) | |
| Total Other Income Expense Net | (2.5M) | 314K | (1.0M) | 67K | 1.7M | 1.7M | |
| Net Income Applicable To Common Shares | (20.7M) | (32.2M) | (48.7M) | (58.9M) | (53.0M) | (50.4M) | |
| Net Income | (20.7M) | (32.2M) | (48.7M) | (58.9M) | (60.8M) | (57.8M) | |
| Income Tax Expense | 363K | 213K | 343K | 353K | 571K | 599.6K | |
| Tax Provision | 363K | 213K | 343K | 353K | 569K | 339.7K | |
| Net Interest Income | (1.9M) | (3.0M) | (429K) | 463K | 2.1M | 2.2M | |
| Interest Income | 432K | 213K | 400K | 1.5M | 4.8M | 5.0M | |
| Depreciation And Amortization | 180K | 400K | 3.2M | 4.0M | 1.9M | 1.8M | |
| Other Operating Expenses | 50.4M | 65.1M | 95.7M | 112.3M | 130.6M | 89.7M | |
| Ebitda | (17.7M) | (28.4M) | (46.6M) | (56.0M) | (55.1M) | (57.8M) | |
| Reconciled Depreciation | 365K | 483K | 867K | 1.5M | 1.6M | 943.3K |
Currently Active Assets on Macroaxis
When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.154 | Return On Assets (0.20) | Return On Equity (0.52) |
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.